HS Icon Vaccines, human use

300220 (Harmonized System 1992 for 6-digit)

World Trade (2018): $30.5B, Rnk 82 / 4726

Top Exporter (2018): $8.15B, Ireland

Top Importer (2018): $7.54B, United States

Product Complexity (2018): 0.68, Rnk 1333 / 4873

Export Growth (CAGR)(2017 - 2018): 24.9%, Rnk 1059 / 4726

Mean Tariff (2018): 0.81%, Rnk 6386 / 6538

Share of World Trade (2018): 0.17%, Rnk 82 / 4726

Overview:  This page contains the latest trade data of Vaccines, human use. In 2018, Vaccines, human use were the world's 82nd most traded product, with a total trade of $30.5B. Between 2017 and 2018 the exports of Vaccines, human use grew by 24.9%, from  $24.4B to $30.5B. Trade in Vaccines, human use represent 0.17% of total world trade.

Exports: In 2018 the top exporters of Vaccines, human use  were Ireland ($8.15B), Belgium-Luxembourg ($6.37B), France ($3.81B), United Kingdom ($3.47B), and United States ($2.52B).

Imports: In 2018 the top importers of Vaccines, human use were United States ($7.54B), Belgium-Luxembourg ($6.45B), United Kingdom ($2.33B), Germany ($1.59B), and France ($988M).

Tariffs: In 2018 the average tariff for Vaccines, human use was 0.81%, been the 6386 lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Vaccines, human use are India (8.18%), Aruba (6%), Pakistan (5.57%), Mongolia (4.98%), and Chad (4.9%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Algeria (0%), Egypt (0%), and Ethiopia (0%).

Ranking: Vaccines, human use ranks 1333rd in the Product Complexity Index (PCI).

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2018): Ireland, $8.15B

Top Destination (2018): United States, $7.54B

Vaccines, human use are the world's 82nd most traded product.

In 2018, the top exporters of Vaccines, human use were Ireland ($8.15B), Belgium-Luxembourg ($6.37B), France ($3.81B), United Kingdom ($3.47B), and United States ($2.52B).

In 2018, the top importers of Vaccines, human use were United States ($7.54B), Belgium-Luxembourg ($6.45B), United Kingdom ($2.33B), Germany ($1.59B), and France ($988M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2017 -  2018): United Kingdom, $2.1B

Top Destination Growth (2017 - 2018): United States, $2.12B

Between 2017 and 2018, the exports of Vaccines, human use grew the fastest in United Kingdom ($2.1B), Belgium-Luxembourg ($1.04B), United States ($936M), France ($839M), and Netherlands ($301M).

Between 2017 and 2018, the fastest growing importers of Vaccines, human use were United States ($2.12B), Belgium-Luxembourg ($1.95B), Germany ($524M), Netherlands ($427M), and Australia ($309M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Vaccines, human use.

In 2018,  market concentration measured using Shannon Entropy, was 3.27. This means that most of the exports of Vaccines, human use are explained by 9 countries.

Explore Visualizations

TOP NET EXPORTER (2018): Ireland, $7.94B

TOP NET IMPORTER (2018): United States, $5.02B

This map shows which countries export or import more of Vaccines, human use. Each country is colored based on the difference in exports and imports of Vaccines, human use during 2018.

In 2018, the countries that had a largest trade value in exports than in imports of Vaccines, human use were Ireland ($7.94B), France ($2.82B), United Kingdom ($1.14B), India ($389M), and Italy ($328M).

In 2018, the countries that had a largest trade value in imports than in exports of Vaccines, human use were United States ($5.02B), Germany ($909M), Brazil ($624M), Saudi Arabia ($424M), and China ($372M).

Trade Forecasts

#permalink to section

This section shows forecasts for total trade for Vaccines, human use. The forecast is based in a long short-term memory model or LSTM constructed using yearly trade data.

Explore Forecasts

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Vaccines, human use was 0.81%.  The countries with the highest tariffs for importing Vaccines, human use were India (8.18%), Aruba (6%), Pakistan (5.57%), Mongolia (4.98%), and Chad (4.9%).

Explore Tariff Data

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Filter

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.